PRESS RELEASE published on 11/02/2023 at 13:30, 2 years 8 months ago Jaguar Health Enters Exclusive Crofelemer Revenue Sharing License and Commercialization Agreement with Quadri Pharmaceuticals Store for Rare Intestinal Failure Diseases in Middle East Markets
PRESS RELEASE published on 11/01/2023 at 13:30, 2 years 8 months ago Issuance of New US Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
PRESS RELEASE published on 10/30/2023 at 13:30, 2 years 8 months ago Magdalena Biosciences, a Joint Venture between Jaguar Health and Filament Health, Receives Second Tranche of Funding from One Small Planet
PRESS RELEASE published on 10/26/2023 at 14:30, 2 years 8 months ago Jaguar Health to Present November 1st at Emerging Growth Conference
PRESS RELEASE published on 10/23/2023 at 14:30, 2 years 8 months ago Magdalena Biosciences Initiates Preclinical Study to Evaluate Plant Extracts to Treat Depression, Anxiety, ADHD and Other Mental Health Indications
PRESS RELEASE published on 10/19/2023 at 14:30, 2 years 8 months ago Independent Study Conducted at Boston Children's Hospital, Harvard Medical School, Shows Potential Utility of Jaguar Health's Crofelemer for Treatment of MVID, a Rare Childhood Disease
PRESS RELEASE published on 10/18/2023 at 14:30, 2 years 8 months ago Napo Pharmaceuticals to Exhibit at the October 25-28 Annual Association of Nurses in AIDS Care (ANAC) Conference for Mytesi, the Company’s FDA-Approved Prescription Drug
PRESS RELEASE published on 10/12/2023 at 14:30, 2 years 8 months ago Jaguar Health to Present October 17 at the Lytham Partners Fall 2023 Investor Conference and October 18 at the BIO Investor Forum
PRESS RELEASE published on 10/10/2023 at 14:30, 2 years 8 months ago Jaguar Animal Health Exhibiting at October 12-14 VCS Annual Conference for Canalevia-CA1, the Company's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
PRESS RELEASE published on 09/28/2023 at 14:30, 2 years 9 months ago Jaguar Health to Present October 3 at LD Micro's Main Event Investor Conference, and on October 5 at the Global Capital Network Investor Conference
Published on 07/03/2026 at 00:45, 9 hours 50 minutes ago FireFox Gold Finalizes Finders Fees on Recent Offering
Published on 07/03/2026 at 00:05, 10 hours 30 minutes ago Update to Tintina Mines Previous Announcement on June 2, 2026 of a C$91 Million Private Placement and Strategic Partnership with the Gignac Family and Sumitomo Corporation for the Development of the Domeyko Sulfuros Copper-Gold Project in Chile
Published on 07/03/2026 at 00:00, 10 hours 35 minutes ago Redwood AI Added to CSE25 Index as One of the Largest Companies Listed on the Canadian Securities Exchange
Published on 07/02/2026 at 23:05, 11 hours 30 minutes ago AI/ML Innovations Announces Completion of Share Issuance
Published on 07/02/2026 at 19:45, 14 hours 50 minutes ago Infield Minerals Issues Shares for Kings Canyon Gold Property Option Payment
Published on 07/03/2026 at 10:03, 32 minutes ago Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Published on 07/03/2026 at 09:00, 1 hour 35 minutes ago Original-Research: HausVorteil AG (von NuWays AG): BUY
Published on 07/03/2026 at 09:00, 1 hour 35 minutes ago Original-Research: LION E-Mobility AG (von NuWays AG): BUY
Published on 07/02/2026 at 18:00, 16 hours 35 minutes ago Outstanding shares and voting rights statement at 30 June 2026
Published on 07/02/2026 at 17:45, 16 hours 50 minutes ago ENGIE to build more than 400 km of new power transmission lines in Peru
Published on 07/02/2026 at 17:45, 16 hours 50 minutes ago Information concerning the total number of voting rights and shares 2026 06 30
Published on 07/02/2026 at 17:45, 16 hours 50 minutes ago EURAZEO COMPLETES THE SALE OF ITS STAKE IN SPANISH HOTEL GROUP FST HOTELS
Published on 07/02/2026 at 17:43, 16 hours 52 minutes ago Aéroports de Paris SA - Shares and voting rights as of 30 June 2026
